Supraventricular Tachycardia (SVT): What's Happening, What to Do at Home, and When to Come In

Why I'm Writing This

If you've ever had your heart suddenly take off racing out of nowhere, felt it pounding at what seemed like twice its normal speed, and had it just as suddenly snap back to normal a few minutes later, you may have had an episode of supraventricular tachycardia. SVT for short. It's one of the most common rhythm problems I see in my cardiology clinic, and it's one of the most misunderstood.

Patients come to me frightened. They think they had a heart attack, or that something is seriously wrong. Most of the time the news is much better than that. SVT in a structurally normal heart is not a heart attack, it is not a stroke, and it is not usually dangerous. It is still frightening and inconvenient, and it deserves a real explanation and a real plan.

This article walks through what SVT is, what to try at home when an episode hits, when to come to the emergency room, and what the long-term options look like. I want you to leave this page with a plan you can actually use.

What SVT Actually Is

Your heart has its own electrical system. A small patch of tissue near the top of the right atrium (the sinus node) fires off the signal that tells the rest of your heart when to beat. That signal travels down through the atria, through a relay station called the AV node, and down into the ventricles. In a normal heart at rest, this happens 60 to 100 times a minute.

In SVT, something short-circuits that orderly process. Instead of one signal per beat, a loop of electrical activity gets set up in the upper part of the heart and starts firing repeatedly at 150 to 220 beats a minute. The ventricles keep up, and you feel your heart racing.

The two most common forms are a mouthful to pronounce, and you don't need to memorize the names. The first is AVNRT (atrioventricular nodal reentrant tachycardia), where the short circuit forms right around the AV node. The second is AVRT (atrioventricular reentrant tachycardia), where an extra electrical pathway that most people don't have creates the loop. What they have in common is the sudden onset, the rapid rate, and the sudden offset. You feel fine, then you don't, then you feel fine again.

SVT is more common in women than men for the nodal type, and first episodes often show up in young adulthood or middle age. Plenty of my patients have had their first episode in their teens and not seen a cardiologist until decades later.

What an Episode Feels Like

The classic story goes like this. You're sitting at your desk, or in line at the grocery store, or just getting up from the couch. Without warning, your heart starts pounding. You feel it in your chest, your neck, sometimes all the way up into your throat. You might feel lightheaded, a little short of breath, or a pressure sensation behind your breastbone. Some patients feel a strong urge to urinate toward the end of an episode, which is the heart releasing a hormone in response to the fast rate.

Episodes usually last a few seconds to a few hours. Most stop on their own. Some stop with something you do on purpose (more on that in a moment). A few need help in the emergency room.

What I want you to pay attention to is what it feels like when the episode ends. In SVT, the ending is as abrupt as the beginning. One moment the heart is racing, the next it's back to a regular rhythm. That sudden off switch is one of the features that helps me distinguish SVT from other causes of palpitations.

What Triggers It

Sometimes nothing. Patients sit still and an episode starts. More often, there's a pattern you can learn to recognize. Common triggers I hear about in clinic:

Caffeine. Coffee, energy drinks, pre-workouts. Not everyone is sensitive to this, but a lot of SVT patients are.

Alcohol. Especially more than a drink or two, or in combination with not enough sleep.

Dehydration and electrolyte shifts. Hot yoga, long runs, a stomach bug, or a day of heavy sweating without enough fluids.

Stimulant medications. Decongestants with pseudoephedrine, ADHD medications, some asthma inhalers, high-dose steroids.

Stress and sleep deprivation. Emotional stress and physical exhaustion both raise your sympathetic tone, which sets the stage.

Hyperthyroidism. An overactive thyroid can provoke SVT. If you've never had your thyroid checked and you're having new episodes, mention this at your next visit.

Temperature extremes can matter too. Several studies have shown that thermal stress, both heat and cold, can set off episodes, particularly in women. That's worth knowing if your episodes seem to cluster in summer or during cold exposure.

The First Thing to Try: Vagal Maneuvers

The vagus nerve is the big parasympathetic nerve that tells your heart to slow down. A vagal maneuver is any action that stimulates that nerve. A strong vagal signal can reset the electrical short circuit and end an SVT episode.

The old-school approach is the standard Valsalva: you take a deep breath and bear down hard, like you're trying to have a bowel movement, for about 15 seconds, then release. It works maybe 1 in 6 times. Not great, but free and safe, so it's always worth trying.

The big improvement came from a randomized trial published in The Lancet in 2015 called REVERT. That's the one I want every SVT patient to know about.

The Modified Valsalva (REVERT Maneuver)

REVERT was a study of 433 adults who came into British emergency departments with SVT. Half were treated with a standard Valsalva. The other half were treated with a modified version that added a postural change at the end. The modified version converted the rhythm back to normal 43 percent of the time, compared to 17 percent for the standard version. More than double the success rate, with no additional risk. It is now considered first-line therapy for a hemodynamically stable SVT episode in most current guidelines.

Here is how the modified Valsalva works. You'll want a partner or family member nearby the first time you try it, because the technique involves someone else helping you change position.

Sit in a semi-reclined position, roughly 45 degrees back. Take a deep breath and strain hard for 15 seconds, as if you were blowing into a straw against resistance. A 10 mL syringe held between your lips works well: blow hard enough to move the plunger. You're aiming for the same effort you'd use to blow up a stiff balloon.

At the end of 15 seconds of straining, have your helper quickly lay you flat and lift both of your legs straight up to a 45-degree angle, holding them there for 15 seconds. Then return to the semi-reclined position for another 45 seconds and check your pulse. If the rhythm has converted, you'll know: the pounding stops and you feel a distinct shift back to normal.

The mechanism is straightforward. The strain phase lowers venous return to the heart, and the sudden leg elevation after the strain sends a wave of blood back up toward the chest. That rapid change in filling activates receptors in the heart and great vessels, which sends a strong vagal signal down to the AV node and interrupts the short circuit.

I always recommend patients watch a video demonstration the first time they learn this, because the coordination matters. There's a good one linked at the end of this article.

A couple of things to know. Don't do this while driving or operating equipment. If you feel like you're going to pass out, stop. And if you're pregnant, have had recent eye surgery, or have been told to avoid straining for another medical reason, talk to me before trying it.

Other Vagal Maneuvers

A few other options that have some evidence behind them, in order of usefulness:

Cold-water face immersion. Filling a sink with cold water and submerging your face for about 15 to 30 seconds activates the same diving reflex that slows the heart of a sea mammal underwater. It works surprisingly well for some patients. A bag of ice held firmly against the center of the face (over the forehead and cheeks) is an acceptable substitute if you can't get to a sink.

Carotid sinus massage. This is something a medical provider does, not something you should do on yourself. Rubbing the right spot on the neck can stimulate the vagus, but it can also dislodge a piece of plaque if you have carotid disease. I don't recommend patients try this at home.

Gagging or coughing hard. These sometimes work, though with much lower success rates than the modified Valsalva. If nothing else is available, they're worth a try.

When Vagal Maneuvers Don't Work: The Emergency Room

If you've tried vagal maneuvers a couple of times at home and the episode is still going, and especially if you're feeling chest pain, severe shortness of breath, lightheadedness, or weakness, the right move is to go to the emergency room. Not urgent care. The ER.

Here's what to expect when you get there.

Adenosine

Adenosine is the main medication for breaking SVT in the ER. It works about 90 percent of the time. It is given as a rapid IV push, 6 milligrams first, followed by a saline flush. If that doesn't work, the dose is doubled to 12 milligrams. Occasionally a third dose of 12 milligrams is given.

Here's the part I want you to hear from me before you hear it in the moment. Adenosine feels awful. For about 10 seconds it causes a sense of heaviness in the chest, flushing, sometimes a feeling like you can't breathe or like impending doom. That sensation stops almost as soon as it starts, because the drug has a half-life of about 10 seconds. It is entirely gone from your system within a minute. The unpleasantness is not a sign that something is going wrong. It's a sign that the drug is doing exactly what it's supposed to do.

When adenosine works, it often works dramatically: you feel the racing heart stop for a second or two, then a pause, then a normal rhythm returns. Many patients describe this as the strangest medical experience they've ever had, followed by an enormous sense of relief.

A few patients shouldn't get adenosine. If you have severe asthma, a heart transplant, or certain forms of Wolff-Parkinson-White with atrial fibrillation, your ER team will use something else.

Calcium Channel Blockers and Beta Blockers

If adenosine doesn't work or isn't appropriate for you, the next line is usually a calcium channel blocker like diltiazem or verapamil, given IV. Beta blockers like metoprolol or esmolol are another option. These convert SVT the majority of the time and have a longer duration of action than adenosine, which is useful if you've had recurrent episodes on the same night.

Synchronized Cardioversion

If you arrive in the ER with an SVT episode and you are unstable (meaning your blood pressure is dropping, you're having chest pain, you're confused, or you're in acute heart failure), the ER team will move to synchronized cardioversion right away. That's an electrical shock, delivered under brief sedation, that resets the heart's rhythm in a single pulse. It sounds dramatic but it's quick, very effective, and you won't remember the shock itself. In stable patients, cardioversion is the last step if medications haven't worked. For SVT, the energy used is low (typically 50 to 100 joules) and the conversion rate is very high.

A New At-Home Option: Etripamil Nasal Spray

In December of 2025 the FDA approved etripamil, a calcium channel blocker delivered as a nasal spray, for patient self-administration during an SVT episode. A phase 3 trial showed it converted SVT to sinus rhythm about 64 percent of the time within 30 minutes, compared to 31 percent with placebo. For patients with frequent SVT episodes who want something stronger than a vagal maneuver but who don't want to keep ending up in the ER, this is a real option worth discussing. Not every patient is a candidate, and it needs to be prescribed and initiated with supervision. If your episodes are frequent enough that this might help, let's talk about it.

The Long-Term Plan

For a first episode of SVT in someone with an otherwise normal heart, often no long-term treatment is needed beyond learning the vagal maneuvers and avoiding triggers. We watch, we check an echocardiogram, we make sure the thyroid is normal, and we see how you do.

For recurrent or bothersome episodes, the conversation usually comes down to two paths: medications, or catheter ablation.

Medications

A daily beta blocker or a non-dihydropyridine calcium channel blocker (diltiazem or verapamil) can reduce the frequency and severity of episodes for many patients. These are generally well tolerated. In patients without structural heart disease, flecainide or propafenone can be used if the first-line agents aren't effective or well tolerated. The catch with lifelong daily medication is that it reduces episodes but rarely eliminates them, and a meaningful number of patients end up back in the ER at some point.

Catheter Ablation

For patients with recurrent symptomatic SVT, catheter ablation is now considered first-line therapy by every major cardiology society. The procedure is done by an electrophysiologist, usually as a day-surgery case. Small catheters are threaded up from veins in the leg to the heart, the electrical short circuit is mapped in detail, and the specific tissue responsible for the loop is cauterized (using heat, called radiofrequency ablation, or cold, called cryoablation).

The success rates are excellent. For AVNRT, a single ablation procedure eliminates the arrhythmia in roughly 94 percent of patients. For the accessory pathway type (AVRT), acute success is close to 99 percent. The complication rate is low. The most serious specific risk is injury to the AV node requiring a permanent pacemaker, which happens in roughly 3 or 4 out of 1,000 patients.

The comparison with medications is striking. A landmark randomized study compared ablation to long-term drug therapy and found zero recurrences in the ablation group over 5 years, versus 68 percent recurrence in the medication group. That's one of the cleanest comparisons in cardiology. For the right patient, ablation is a cure.

I bring up ablation early in the conversation for patients who are young, active, or whose episodes are affecting quality of life. The idea of a one-time procedure that fixes the problem is attractive to a lot of people. It is also the right choice for most athletes, for patients whose jobs involve heights, driving, or operating equipment, and for anyone whose episodes are frequent enough that daily medication is the only alternative.

When SVT Is an Emergency

Most SVT episodes are uncomfortable but not dangerous. A few are. Call 911 or go to the nearest ER right away if an episode is accompanied by any of the following:

Chest pain or pressure that doesn't let up, especially if it radiates to the jaw, shoulder, or arm.

Severe shortness of breath, especially if you feel like you can't get a full breath or you're starting to wheeze.

Fainting or near-fainting, or a feeling that you're about to pass out and can't keep yourself upright.

Confusion, severe weakness, or cold clammy skin. These can be signs that blood pressure is dropping.

An episode that has gone on for more than an hour and hasn't responded to vagal maneuvers, especially if you've never had an episode last this long before.

You know your body. If something about this episode feels different or scarier than your usual pattern, trust that and get evaluated. I would rather see you in the ER for a false alarm than miss something that matters.

What SVT Is Not

A lot of patients arrive in my office convinced their SVT episode was a heart attack. Understandable, because both can involve a racing heart and chest sensations. They are different.

A heart attack is caused by a blocked coronary artery starving heart muscle of oxygen. SVT is an electrical short circuit in an otherwise healthy heart. SVT doesn't damage the heart muscle in a structurally normal heart. It doesn't cause plaque to rupture. It doesn't increase your risk of having a heart attack next week.

SVT is also not atrial fibrillation. AFib is a different rhythm problem with different causes, different risks (including stroke), and a different treatment approach. If you've been told you have SVT, don't assume what you read about AFib applies to you. It usually doesn't.

Finally, SVT is almost never a reason to give up exercise, travel, or activities you love. For the vast majority of patients, episodes are infrequent enough and terminable enough that you can keep living your life. If episodes are frequent enough to interfere with what you want to do, that's a strong indication for catheter ablation.

Managing Expectations

If you've had one episode, there's a reasonable chance you'll have another. It might be weeks, it might be years. I don't try to promise a specific timeline because SVT is a variable condition.

If you're on medication, expect fewer and shorter episodes, not zero episodes. That's the realistic goal for most patients on daily rhythm medication.

If you've had a successful ablation, expect the problem to stay fixed. Recurrence rates vary by type (around 17 percent over a few years for AVNRT, lower for AVRT), and if an episode does recur, a repeat ablation almost always fixes it.

If you're tracking your episodes with an Apple Watch, a KardiaMobile, or a Fitbit, bring those recordings to your visit. A rhythm strip captured at home during an episode is one of the most useful things you can hand me. For SVT, it often shows a narrow QRS complex at a rate of 150 to 220, sometimes with P waves buried in the QRS or just after it. A single 30-second recording like this can save you weeks of monitor wear.

How This Fits Into Your Overall Care

An SVT diagnosis doesn't mean a parade of procedures. For most patients it means a basic workup to rule out structural causes (usually an echocardiogram and a thyroid panel), a conversation about triggers, a plan for terminating episodes at home, and an agreement about when to come in. For patients with frequent episodes, it means a referral to an electrophysiologist and a discussion about ablation.

If you have other cardiovascular issues (high blood pressure, coronary disease, heart failure), SVT management still mostly follows the same logic, but I coordinate medications carefully so the SVT plan doesn't conflict with the rest of your treatment. That's one of the reasons it's helpful to have a cardiologist overseeing the whole picture.

Making the Decision

For a first episode in a structurally normal heart: learn the vagal maneuvers, avoid obvious triggers, get a basic workup, and see what happens. If episodes stay rare, you may never need more than that.

For recurrent episodes that are interfering with life: the conversation is usually medication versus ablation. My bias is toward ablation for most patients who are otherwise healthy, because the cure rate is high, the complication rate is low, and the alternative is years of daily pills and unpredictable episodes. That said, not every patient wants a procedure, and medication is a reasonable path for patients who prefer it or who have other reasons to avoid ablation.

For patients with structural heart disease, Wolff-Parkinson-White, frequent syncope, or unstable episodes: the workup gets more detailed and the ablation conversation moves to the front of the line. These are cases where I want a specialist electrophysiologist involved early.

The Bottom Line

SVT is common, it is treatable, and in most people it is not dangerous. Learn the modified Valsalva. Know your triggers. Know when to come to the ER. If episodes are interfering with your life, know that ablation is an excellent option. The goal is not to fear the next episode. It's to have a plan so the next episode doesn't run your day.

Frequently Asked Questions

Is SVT dangerous?

In a structurally normal heart, the great majority of SVT episodes are uncomfortable but not dangerous. In patients with other cardiac conditions or with specific accessory pathway disorders like Wolff-Parkinson-White, SVT can occasionally lead to more serious problems, which is part of why a cardiology evaluation matters.

Can SVT turn into a heart attack?

No. SVT is an electrical rhythm problem and a heart attack is a plumbing problem caused by a blocked coronary artery. One doesn't turn into the other. If you have chest pressure during an SVT episode in the setting of known coronary disease, that's a separate issue that deserves evaluation.

Can I exercise with SVT?

Usually yes. Exercise can sometimes trigger an episode, but for most patients, SVT is not a reason to stop being active. If episodes are frequent during exercise, that's often the point where I start talking about ablation.

How long does an SVT episode usually last?

Anywhere from a few seconds to a few hours. Most stop within minutes. If an episode is going past an hour and isn't responding to vagal maneuvers, come to the ER.

Will I need a pacemaker?

Almost never. SVT itself doesn't cause the slow-heart problems that pacemakers treat. The small risk of needing a pacemaker is as a rare complication of AV node ablation, which happens in about 3 or 4 out of 1,000 procedures.

Does ablation work the first time?

For AVNRT, the first procedure succeeds in about 94 percent of patients. For accessory pathway SVT, the acute success rate is close to 99 percent. If a rare recurrence happens, a repeat procedure nearly always fixes it.

Can I drink coffee again?

Depends on you. Some SVT patients are clearly sensitive to caffeine and should limit or avoid it. Others tolerate it fine. Track your episodes in relation to your intake for a few weeks and you'll usually see a pattern.

Is adenosine safe?

Yes. The side effects feel terrible for about 10 seconds, which is how long the drug is in your system. Serious complications are rare. The ER team monitors you closely during the dose.

Can my Apple Watch diagnose SVT?

It can capture a rhythm strip during an episode, and that strip is often enough for me to make the diagnosis. The automated interpretation is less reliable for SVT than for atrial fibrillation. Capture the strip and bring it to me.

Is SVT the same as atrial fibrillation?

No. Both are rhythm problems originating above the ventricles, but they have different mechanisms, different patterns, different stroke risks, and different treatments. If you've been diagnosed with SVT, the AFib information you see online probably doesn't apply to your situation.

A Video Worth Watching

For a clear demonstration of the modified Valsalva maneuver as it was performed in the REVERT trial, I recommend the official Lancet TV video from the trial team in England, available on YouTube: Modified Valsalva manoeuvre for supraventricular tachycardia. It's under two minutes long and shows the position, the strain, and the leg lift clearly. Watch it once before you try the technique, and watch it again with the family member who is going to help you do it.

References

1. Appelboam, Andrew, Adam Reuben, Clifford Mann, James Gagg, Paul Ewings, Andrew Barton, Trudie Lobban, Ivan Dayer, Jane Vickery, and Jonathan Benger. "Postural Modification to the Standard Valsalva Manoeuvre for Emergency Treatment of Supraventricular Tachycardias (REVERT): A Randomised Controlled Trial." The Lancet 386, no. 10005 (2015): 1747-1753.

2. Peng, Grace, and Paul C. Zei. "Diagnosis and Management of Paroxysmal Supraventricular Tachycardia." JAMA 331, no. 7 (2024): 601-610.

3. Page, Richard L., Jose A. Joglar, Mary A. Caldwell, Hugh Calkins, Jamie B. Conti, Barbara J. Deal, N.A. Mark Estes III, et al. "2015 ACC/AHA/HRS Guideline for the Management of Adult Patients with Supraventricular Tachycardia." Journal of the American College of Cardiology 67, no. 13 (2016): e27-e115.

4. Brugada, Josep, Demosthenes G. Katritsis, Elena Arbelo, Fernando Arribas, Jeroen J. Bax, Carina Blomstrom-Lundqvist, Hugh Calkins, et al. "2019 ESC Guidelines for the Management of Patients with Supraventricular Tachycardia." European Heart Journal 41, no. 5 (2020): 655-720.

5. Stambler, Bruce S., Alejandro Camacho, Sandra Gaudio, Douglas Wieczorek, and Philip T. Sager. "Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm." Journal of the American College of Cardiology 72, no. 5 (2018): 489-497.

6. Stambler, Bruce S., Paul Dorian, Bernard Belardinelli, Benoit Coutu, James M. Ip, Oussama Wazni, Peter Kowey, et al. "Etripamil for Rapid Termination of Paroxysmal Supraventricular Tachycardia: The NODE-301 Randomized Clinical Trial." Circulation 148, no. 1 (2023): 7-17.

7. Orejarena, Luis A., Hugh Vidaillet Jr., Fernando DeStefano, Diane L. Nordstrom, Robert A. Vierkant, Para N. Smith, and John K. Hayes. "Paroxysmal Supraventricular Tachycardia in the General Population." Journal of the American College of Cardiology 31, no. 1 (1998): 150-157.

8. Katritsis, Demosthenes G., and A. John Camm. "Atrioventricular Nodal Reentrant Tachycardia." Circulation 122, no. 8 (2010): 831-840.

9. Bohnen, Marius, William G. Stevenson, Usha B. Tedrow, Laurence M. Epstein, Gregory F. Michaud, Bruce A. Koplan, Samuel H. Sepehri Shamloo, and Roy M. John. "Incidence and Predictors of Major Complications from Contemporary Catheter Ablation to Treat Cardiac Arrhythmias." Heart Rhythm 8, no. 11 (2011): 1661-1666.

10. Hanninen, Mikael, Stephen B. Yeung-Lai-Wah, Jason G. Andrade, Santabhanu Chakrabarti, Nathaniel Hawkins, John A. Yeung-Lai-Wah, Marc W. Deyell, Matthew T. Bennett, and Laurent Macle. "Cryoablation Versus RF Ablation for AVNRT: A Meta-Analysis and Systematic Review." Journal of Cardiovascular Electrophysiology 24, no. 12 (2013): 1354-1360.

11. Alboni, Paolo, Cristian Tomasi, Carlo Menozzi, Nicola Bottoni, Nicoletta Paparella, Maddalena Fuca, Massimo Brignole, and Gabriele Cappato. "Efficacy and Safety of Out-of-Hospital Self-Administered Single-Dose Oral Drug Treatment in the Management of Infrequent, Well-Tolerated Paroxysmal Supraventricular Tachycardia." Journal of the American College of Cardiology 37, no. 2 (2001): 548-553.

12. US Food and Drug Administration. "FDA Approves Etripamil Nasal Spray (Cardamyst) for Paroxysmal Supraventricular Tachycardia." FDA News Release, December 2025.